112960-56-2 Usage
General Description
(3-Methyl-1,2,4-oxadiazol-5-yl)methanol is a chemically synthesized compound with a structure characterized by the presence of an oxadiazole ring. This chemical group is part of a larger class of azoles, which are nitrogen-containing heterocycles. As implied by its name, (3-methyl-1,2,4-oxadiazol-5-yl)methanol also includes a methyl group and a methanol group. While the specific properties and use of this exact compound may vary, oxadiazoles in general are commonly researched for their potential medicinal applications, especially as anticancer, antimicrobial, and anti-inflammatory agents. They are also used in the manufacture of materials due to their thermal stability and resistive properties.
Check Digit Verification of cas no
The CAS Registry Mumber 112960-56-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,9,6 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 112960-56:
(8*1)+(7*1)+(6*2)+(5*9)+(4*6)+(3*0)+(2*5)+(1*6)=112
112 % 10 = 2
So 112960-56-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H6N2O2/c1-3-5-4(2-7)8-6-3/h7H,2H2,1H3
112960-56-2Relevant articles and documents
COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES
-
Page/Page column 101, (2019/07/19)
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.
COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES
-
Page/Page column 98, (2019/07/19)
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.
Amino-Containing Compounds Which Inhibit Memapsin 2 Beta-Secretase Activity and Methods of Use Thereof
-
Page/Page column 21, (2008/12/05)
The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease.
